Orthopediatrics (KIDS) EPS (Weighted Average and Diluted) (2019 - 2026)

Orthopediatrics' EPS (Weighted Average and Diluted) history runs 8 years deep, the most recent figure standing at -$0.45 for Q1 2026.

• In Q1 2026, EPS (Weighted Average and Diluted) rose 2.17% year-over-year to -$0.45; the TTM figure through Mar 2026 stood at -$1.68 (up 4.55% YoY), while the FY2025 annual figure was -$1.69, down 3.05% from the prior year.
• EPS (Weighted Average and Diluted) was -$0.45 for Q1 2026 at Orthopediatrics, down from -$0.43 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.87 in Q3 2022 to a low of -$0.7 in Q4 2024.
• Historically, EPS (Weighted Average and Diluted) has averaged -$0.28 across 5 years, with a median of -$0.34 in 2024.
• Biggest YoY gain for EPS (Weighted Average and Diluted) was 890.91% in 2022; the steepest drop was 10001.74% in 2022.
• A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.37 in 2022, then gained by 21.62% to -$0.29 in 2023, then sank by 141.38% to -$0.7 in 2024, then surged by 38.57% to -$0.43 in 2025, then declined by 4.65% to -$0.45 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at -$0.45 (Q1 2026), -$0.43 (Q4 2025), and -$0.5 (Q3 2025), per Business Quant data.